Berkshire buys Teva, bites more Apple, feels IBM blues

Business


(Reuters) – Warren Buffett’s Berkshire Hathaway Inc (BRKa.N) on Wednesday said it has taken a new stake in Teva Pharmaceutical Industries Ltd (TEVA.TA), significantly boosted its holdings of Apple Inc (AAPL.O) and has nearly shed a less successful investment in IBM Corp (IBM.N).

In a regulatory filing detailing its U.S.-listed stock holdings as of Dec. 31, Berkshire reported owning about 18.9 million of the American depositary receipts in Teva, one of the world’s largest generic drug makers, worth about $358 million.

Teva’s share price rose more than 10 percent after Berkshire reported its ownership stake.

Berkshire also reported a 23 percent increase since the end of September in its Apple stake, to about 165.3 million shares, and a 94.5 percent decline in its stake in International Business Machines Corp, to 2.05 million shares.

Reporting by Jonathan Stempel in New York; Editing by Leslie Adler



Source link

Products You May Like

Articles You May Like

Lotte chief arrested, ex-president
Pentagon chief urges Turkey to stay focused on fighting Islamic State
Proxy advisory firm ISS says Qualcomm should negotiate sale to…
U.S. defense chief says talks with Turkey on Syria
Switzerland makes it illegal to boil a lobster

Leave a Reply

Your email address will not be published. Required fields are marked *